nodes	percent_of_prediction	percent_of_DWPC	metapath
Adapalene—RXRA—prostate cancer	0.656	1	CbGaD
Adapalene—Foetal disorder—Estradiol—prostate cancer	0.0102	0.0918	CcSEcCtD
Adapalene—RARB—prostate gland—prostate cancer	0.00429	0.123	CbGeAlD
Adapalene—RXRG—prostate gland—prostate cancer	0.00419	0.12	CbGeAlD
Adapalene—Drug ineffective—Estradiol—prostate cancer	0.00355	0.0319	CcSEcCtD
Adapalene—RARG—prostate gland—prostate cancer	0.0035	0.1	CbGeAlD
Adapalene—RARA—prostate gland—prostate cancer	0.00329	0.0942	CbGeAlD
Adapalene—RXRA—renal system—prostate cancer	0.00326	0.0932	CbGeAlD
Adapalene—Pain of skin—Estradiol—prostate cancer	0.00261	0.0235	CcSEcCtD
Adapalene—RARG—urethra—prostate cancer	0.00234	0.0671	CbGeAlD
Adapalene—RARA—renal system—prostate cancer	0.00224	0.0642	CbGeAlD
Adapalene—Keratoconjunctivitis—Capecitabine—prostate cancer	0.0021	0.0189	CcSEcCtD
Adapalene—Sunburn—Estradiol—prostate cancer	0.00204	0.0183	CcSEcCtD
Adapalene—RXRG—testis—prostate cancer	0.00185	0.0529	CbGeAlD
Adapalene—Herpes labialis—Epirubicin—prostate cancer	0.00184	0.0166	CcSEcCtD
Adapalene—RXRB—testis—prostate cancer	0.00174	0.0497	CbGeAlD
Adapalene—Herpes labialis—Doxorubicin—prostate cancer	0.00171	0.0153	CcSEcCtD
Adapalene—RARA—bone marrow—prostate cancer	0.0017	0.0486	CbGeAlD
Adapalene—Skin exfoliation—Estramustine—prostate cancer	0.00166	0.0149	CcSEcCtD
Adapalene—Oral herpes—Capecitabine—prostate cancer	0.00163	0.0146	CcSEcCtD
Adapalene—RARG—testis—prostate cancer	0.00154	0.0441	CbGeAlD
Adapalene—RARA—testis—prostate cancer	0.00145	0.0415	CbGeAlD
Adapalene—Eye pain—Estramustine—prostate cancer	0.0014	0.0126	CcSEcCtD
Adapalene—RARB—lymph node—prostate cancer	0.00137	0.0392	CbGeAlD
Adapalene—Optic neuritis—Conjugated Estrogens—prostate cancer	0.00125	0.0112	CcSEcCtD
Adapalene—Eyelid oedema—Estradiol—prostate cancer	0.00122	0.011	CcSEcCtD
Adapalene—Dermatitis bullous—Flutamide—prostate cancer	0.00117	0.0105	CcSEcCtD
Adapalene—Dry skin—Estramustine—prostate cancer	0.00116	0.0104	CcSEcCtD
Adapalene—Seborrhoeic dermatitis—Goserelin—prostate cancer	0.00114	0.0102	CcSEcCtD
Adapalene—Oral herpes—Epirubicin—prostate cancer	0.00114	0.0102	CcSEcCtD
Adapalene—RARG—lymph node—prostate cancer	0.00112	0.032	CbGeAlD
Adapalene—Papilloedema—Prednisone—prostate cancer	0.00108	0.00966	CcSEcCtD
Adapalene—Oral herpes—Doxorubicin—prostate cancer	0.00105	0.00943	CcSEcCtD
Adapalene—RARA—lymph node—prostate cancer	0.00105	0.0301	CbGeAlD
Adapalene—Dry skin—Nilutamide—prostate cancer	0.00103	0.00924	CcSEcCtD
Adapalene—Herpes simplex—Ethinyl Estradiol—prostate cancer	0.00102	0.0092	CcSEcCtD
Adapalene—Optic neuritis—Estradiol—prostate cancer	0.001	0.00899	CcSEcCtD
Adapalene—Feeling hot—Conjugated Estrogens—prostate cancer	0.000981	0.0088	CcSEcCtD
Adapalene—Redness—Estradiol—prostate cancer	0.000912	0.00819	CcSEcCtD
Adapalene—Photosensitivity reaction—Flutamide—prostate cancer	0.000882	0.00792	CcSEcCtD
Adapalene—Dry skin—Cabazitaxel—prostate cancer	0.000866	0.00778	CcSEcCtD
Adapalene—Skin discolouration—Goserelin—prostate cancer	0.00086	0.00772	CcSEcCtD
Adapalene—Herpes simplex—Goserelin—prostate cancer	0.000843	0.00757	CcSEcCtD
Adapalene—Face oedema—Bicalutamide—prostate cancer	0.000783	0.00703	CcSEcCtD
Adapalene—Optic neuritis—Etoposide—prostate cancer	0.000776	0.00697	CcSEcCtD
Adapalene—Hepatitis—Flutamide—prostate cancer	0.000774	0.00694	CcSEcCtD
Adapalene—Eczema—Ethinyl Estradiol—prostate cancer	0.000763	0.00685	CcSEcCtD
Adapalene—Dry skin—Bicalutamide—prostate cancer	0.000743	0.00667	CcSEcCtD
Adapalene—Conjunctivitis—Cabazitaxel—prostate cancer	0.000708	0.00636	CcSEcCtD
Adapalene—Skin discolouration—Estradiol—prostate cancer	0.000682	0.00612	CcSEcCtD
Adapalene—Erythema—Flutamide—prostate cancer	0.000673	0.00604	CcSEcCtD
Adapalene—Herpes simplex—Estradiol—prostate cancer	0.000668	0.006	CcSEcCtD
Adapalene—Angioedema—Estrone—prostate cancer	0.000665	0.00597	CcSEcCtD
Adapalene—Dermatitis contact—Estradiol—prostate cancer	0.000609	0.00546	CcSEcCtD
Adapalene—Conjunctivitis—Bicalutamide—prostate cancer	0.000607	0.00545	CcSEcCtD
Adapalene—Erythema—Degarelix—prostate cancer	0.000604	0.00542	CcSEcCtD
Adapalene—Keratitis—Capecitabine—prostate cancer	0.000592	0.00532	CcSEcCtD
Adapalene—Skin exfoliation—Estradiol—prostate cancer	0.000588	0.00528	CcSEcCtD
Adapalene—Redness—Docetaxel—prostate cancer	0.000588	0.00528	CcSEcCtD
Adapalene—Dermatitis bullous—Conjugated Estrogens—prostate cancer	0.000585	0.00525	CcSEcCtD
Adapalene—Angioedema—Estradiol valerate/Dienogest—prostate cancer	0.000581	0.00521	CcSEcCtD
Adapalene—Burning sensation—Docetaxel—prostate cancer	0.000571	0.00513	CcSEcCtD
Adapalene—Erythema—Cabazitaxel—prostate cancer	0.000569	0.00511	CcSEcCtD
Adapalene—Optic neuritis—Prednisone—prostate cancer	0.000556	0.00499	CcSEcCtD
Adapalene—Dermatitis atopic—Docetaxel—prostate cancer	0.000536	0.00481	CcSEcCtD
Adapalene—Skin discolouration—Etoposide—prostate cancer	0.000529	0.00474	CcSEcCtD
Adapalene—Dry skin—Goserelin—prostate cancer	0.000517	0.00464	CcSEcCtD
Adapalene—Pain—Estrone—prostate cancer	0.000508	0.00456	CcSEcCtD
Adapalene—Eczema—Estradiol—prostate cancer	0.000498	0.00447	CcSEcCtD
Adapalene—Vesiculobullous rash—Epirubicin—prostate cancer	0.000477	0.00429	CcSEcCtD
Adapalene—Urticaria—Estrone—prostate cancer	0.000472	0.00424	CcSEcCtD
Adapalene—Pain—Nilutamide—prostate cancer	0.000472	0.00424	CcSEcCtD
Adapalene—Dermatitis atopic—Prednisone—prostate cancer	0.000462	0.00415	CcSEcCtD
Adapalene—Skin exfoliation—Etoposide—prostate cancer	0.000456	0.00409	CcSEcCtD
Adapalene—Angioedema—Bicalutamide—prostate cancer	0.000446	0.00401	CcSEcCtD
Adapalene—Photosensitivity reaction—Goserelin—prostate cancer	0.000445	0.00399	CcSEcCtD
Adapalene—Pain—Estradiol valerate/Dienogest—prostate cancer	0.000444	0.00398	CcSEcCtD
Adapalene—Vesiculobullous rash—Doxorubicin—prostate cancer	0.000442	0.00397	CcSEcCtD
Adapalene—Pruritus—Estramustine—prostate cancer	0.00044	0.00395	CcSEcCtD
Adapalene—Optic neuritis—Epirubicin—prostate cancer	0.000435	0.00391	CcSEcCtD
Adapalene—Face oedema—Estradiol—prostate cancer	0.000432	0.00388	CcSEcCtD
Adapalene—Skin discolouration—Capecitabine—prostate cancer	0.000425	0.00382	CcSEcCtD
Adapalene—Pain—Degarelix—prostate cancer	0.000422	0.00379	CcSEcCtD
Adapalene—Pruritus—Estrone—prostate cancer	0.00042	0.00377	CcSEcCtD
Adapalene—Herpes simplex—Capecitabine—prostate cancer	0.000417	0.00374	CcSEcCtD
Adapalene—Keratitis—Epirubicin—prostate cancer	0.000413	0.0037	CcSEcCtD
Adapalene—Urticaria—Estradiol valerate/Dienogest—prostate cancer	0.000412	0.0037	CcSEcCtD
Adapalene—Dry skin—Estradiol—prostate cancer	0.00041	0.00368	CcSEcCtD
Adapalene—Optic neuritis—Doxorubicin—prostate cancer	0.000403	0.00361	CcSEcCtD
Adapalene—Pain—Cabazitaxel—prostate cancer	0.000397	0.00357	CcSEcCtD
Adapalene—Redness—Epirubicin—prostate cancer	0.000396	0.00356	CcSEcCtD
Adapalene—Seborrhoeic dermatitis—Epirubicin—prostate cancer	0.000393	0.00352	CcSEcCtD
Adapalene—Rash—Estramustine—prostate cancer	0.000392	0.00352	CcSEcCtD
Adapalene—Dermatitis—Estramustine—prostate cancer	0.000392	0.00352	CcSEcCtD
Adapalene—Urticaria—Degarelix—prostate cancer	0.000392	0.00352	CcSEcCtD
Adapalene—Pruritus—Nilutamide—prostate cancer	0.000391	0.00351	CcSEcCtD
Adapalene—Hepatitis—Goserelin—prostate cancer	0.00039	0.0035	CcSEcCtD
Adapalene—Pruritus—Flutamide—prostate cancer	0.000389	0.00349	CcSEcCtD
Adapalene—Burning sensation—Epirubicin—prostate cancer	0.000385	0.00346	CcSEcCtD
Adapalene—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.000382	0.00343	CcSEcCtD
Adapalene—Keratitis—Doxorubicin—prostate cancer	0.000382	0.00343	CcSEcCtD
Adapalene—Rash—Abiraterone—prostate cancer	0.000381	0.00342	CcSEcCtD
Adapalene—Dermatitis—Abiraterone—prostate cancer	0.000381	0.00342	CcSEcCtD
Adapalene—Skin exfoliation—Docetaxel—prostate cancer	0.000379	0.0034	CcSEcCtD
Adapalene—Angioedema—Ethinyl Estradiol—prostate cancer	0.000377	0.00339	CcSEcCtD
Adapalene—Rash—Estrone—prostate cancer	0.000375	0.00336	CcSEcCtD
Adapalene—Dermatitis—Estrone—prostate cancer	0.000374	0.00336	CcSEcCtD
Adapalene—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.000367	0.00329	CcSEcCtD
Adapalene—Redness—Doxorubicin—prostate cancer	0.000367	0.00329	CcSEcCtD
Adapalene—Skin exfoliation—Capecitabine—prostate cancer	0.000367	0.00329	CcSEcCtD
Adapalene—Hypersensitivity—Degarelix—prostate cancer	0.000363	0.00326	CcSEcCtD
Adapalene—Seborrhoeic dermatitis—Doxorubicin—prostate cancer	0.000363	0.00326	CcSEcCtD
Adapalene—Dermatitis atopic—Epirubicin—prostate cancer	0.000362	0.00325	CcSEcCtD
Adapalene—Burning sensation—Doxorubicin—prostate cancer	0.000356	0.0032	CcSEcCtD
Adapalene—Photosensitivity reaction—Estradiol—prostate cancer	0.000353	0.00317	CcSEcCtD
Adapalene—Pruritus—Degarelix—prostate cancer	0.000349	0.00313	CcSEcCtD
Adapalene—Rash—Nilutamide—prostate cancer	0.000348	0.00312	CcSEcCtD
Adapalene—Dermatitis—Nilutamide—prostate cancer	0.000348	0.00312	CcSEcCtD
Adapalene—Rash—Flutamide—prostate cancer	0.000347	0.00311	CcSEcCtD
Adapalene—Dermatitis—Flutamide—prostate cancer	0.000346	0.00311	CcSEcCtD
Adapalene—Hypersensitivity—Cabazitaxel—prostate cancer	0.000342	0.00307	CcSEcCtD
Adapalene—Feeling hot—Epirubicin—prostate cancer	0.000341	0.00306	CcSEcCtD
Adapalene—Pain—Bicalutamide—prostate cancer	0.000341	0.00306	CcSEcCtD
Adapalene—Erythema—Goserelin—prostate cancer	0.00034	0.00305	CcSEcCtD
Adapalene—Erythema—Conjugated Estrogens—prostate cancer	0.000336	0.00302	CcSEcCtD
Adapalene—Rash pustular—Epirubicin—prostate cancer	0.000336	0.00301	CcSEcCtD
Adapalene—Conjunctivitis—Estradiol—prostate cancer	0.000335	0.00301	CcSEcCtD
Adapalene—Dermatitis atopic—Doxorubicin—prostate cancer	0.000335	0.003	CcSEcCtD
Adapalene—Stinging—Epirubicin—prostate cancer	0.00033	0.00297	CcSEcCtD
Adapalene—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000327	0.00294	CcSEcCtD
Adapalene—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000327	0.00293	CcSEcCtD
Adapalene—Skin exfoliation—Prednisone—prostate cancer	0.000327	0.00293	CcSEcCtD
Adapalene—Urticaria—Bicalutamide—prostate cancer	0.000317	0.00284	CcSEcCtD
Adapalene—Feeling hot—Doxorubicin—prostate cancer	0.000315	0.00283	CcSEcCtD
Adapalene—Conjunctivitis—Mitoxantrone—prostate cancer	0.000312	0.0028	CcSEcCtD
Adapalene—Rash—Degarelix—prostate cancer	0.000311	0.00279	CcSEcCtD
Adapalene—Dermatitis—Degarelix—prostate cancer	0.000311	0.00279	CcSEcCtD
Adapalene—Rash pustular—Doxorubicin—prostate cancer	0.00031	0.00279	CcSEcCtD
Adapalene—Hepatitis—Estradiol—prostate cancer	0.000309	0.00278	CcSEcCtD
Adapalene—Eye pain—Capecitabine—prostate cancer	0.000309	0.00277	CcSEcCtD
Adapalene—Angioedema—Conjugated Estrogens—prostate cancer	0.000307	0.00276	CcSEcCtD
Adapalene—Stinging—Doxorubicin—prostate cancer	0.000306	0.00274	CcSEcCtD
Adapalene—Dermatitis bullous—Docetaxel—prostate cancer	0.000301	0.00271	CcSEcCtD
Adapalene—Skin discolouration—Epirubicin—prostate cancer	0.000296	0.00266	CcSEcCtD
Adapalene—Dermatitis exfoliative—Capecitabine—prostate cancer	0.000296	0.00265	CcSEcCtD
Adapalene—Convulsion—Goserelin—prostate cancer	0.000294	0.00264	CcSEcCtD
Adapalene—Hypersensitivity—Bicalutamide—prostate cancer	0.000294	0.00264	CcSEcCtD
Adapalene—Dermatitis bullous—Capecitabine—prostate cancer	0.000292	0.00262	CcSEcCtD
Adapalene—Convulsion—Conjugated Estrogens—prostate cancer	0.000292	0.00262	CcSEcCtD
Adapalene—Herpes simplex—Epirubicin—prostate cancer	0.00029	0.00261	CcSEcCtD
Adapalene—Hepatitis—Mitoxantrone—prostate cancer	0.000288	0.00259	CcSEcCtD
Adapalene—Pruritus—Bicalutamide—prostate cancer	0.000282	0.00253	CcSEcCtD
Adapalene—Skin discolouration—Doxorubicin—prostate cancer	0.000274	0.00246	CcSEcCtD
Adapalene—Erythema—Estradiol—prostate cancer	0.000269	0.00242	CcSEcCtD
Adapalene—Face oedema—Capecitabine—prostate cancer	0.000269	0.00242	CcSEcCtD
Adapalene—Herpes simplex—Doxorubicin—prostate cancer	0.000269	0.00241	CcSEcCtD
Adapalene—Urticaria—Ethinyl Estradiol—prostate cancer	0.000268	0.0024	CcSEcCtD
Adapalene—Dermatitis contact—Epirubicin—prostate cancer	0.000264	0.00237	CcSEcCtD
Adapalene—Dry skin—Docetaxel—prostate cancer	0.000264	0.00237	CcSEcCtD
Adapalene—Dry skin—Capecitabine—prostate cancer	0.000256	0.00229	CcSEcCtD
Adapalene—Skin exfoliation—Epirubicin—prostate cancer	0.000255	0.00229	CcSEcCtD
Adapalene—Rash—Bicalutamide—prostate cancer	0.000251	0.00226	CcSEcCtD
Adapalene—Dermatitis—Bicalutamide—prostate cancer	0.000251	0.00225	CcSEcCtD
Adapalene—Erythema—Mitoxantrone—prostate cancer	0.000251	0.00225	CcSEcCtD
Adapalene—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000248	0.00223	CcSEcCtD
Adapalene—Angioedema—Estradiol—prostate cancer	0.000246	0.00221	CcSEcCtD
Adapalene—Dermatitis contact—Doxorubicin—prostate cancer	0.000245	0.0022	CcSEcCtD
Adapalene—Face oedema—Prednisone—prostate cancer	0.00024	0.00215	CcSEcCtD
Adapalene—Pruritus—Ethinyl Estradiol—prostate cancer	0.000238	0.00214	CcSEcCtD
Adapalene—Pain—Goserelin—prostate cancer	0.000237	0.00213	CcSEcCtD
Adapalene—Skin exfoliation—Doxorubicin—prostate cancer	0.000236	0.00212	CcSEcCtD
Adapalene—Pain—Conjugated Estrogens—prostate cancer	0.000235	0.00211	CcSEcCtD
Adapalene—Dry skin—Prednisone—prostate cancer	0.000228	0.00204	CcSEcCtD
Adapalene—Urticaria—Goserelin—prostate cancer	0.00022	0.00198	CcSEcCtD
Adapalene—Photosensitivity reaction—Capecitabine—prostate cancer	0.00022	0.00197	CcSEcCtD
Adapalene—Urticaria—Conjugated Estrogens—prostate cancer	0.000218	0.00196	CcSEcCtD
Adapalene—Convulsion—Mitoxantrone—prostate cancer	0.000217	0.00195	CcSEcCtD
Adapalene—Eczema—Epirubicin—prostate cancer	0.000216	0.00194	CcSEcCtD
Adapalene—Conjunctivitis—Docetaxel—prostate cancer	0.000216	0.00194	CcSEcCtD
Adapalene—Eye pain—Epirubicin—prostate cancer	0.000215	0.00193	CcSEcCtD
Adapalene—Rash—Ethinyl Estradiol—prostate cancer	0.000212	0.00191	CcSEcCtD
Adapalene—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000212	0.0019	CcSEcCtD
Adapalene—Conjunctivitis—Capecitabine—prostate cancer	0.000209	0.00188	CcSEcCtD
Adapalene—Dermatitis exfoliative—Epirubicin—prostate cancer	0.000206	0.00185	CcSEcCtD
Adapalene—Hypersensitivity—Goserelin—prostate cancer	0.000204	0.00183	CcSEcCtD
Adapalene—Dermatitis bullous—Epirubicin—prostate cancer	0.000203	0.00182	CcSEcCtD
Adapalene—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000202	0.00182	CcSEcCtD
Adapalene—Eczema—Doxorubicin—prostate cancer	0.0002	0.0018	CcSEcCtD
Adapalene—Hepatitis—Docetaxel—prostate cancer	0.000199	0.00179	CcSEcCtD
Adapalene—Eye pain—Doxorubicin—prostate cancer	0.000199	0.00179	CcSEcCtD
Adapalene—Pruritus—Goserelin—prostate cancer	0.000196	0.00176	CcSEcCtD
Adapalene—Pruritus—Conjugated Estrogens—prostate cancer	0.000194	0.00174	CcSEcCtD
Adapalene—Hepatitis—Capecitabine—prostate cancer	0.000193	0.00173	CcSEcCtD
Adapalene—Dermatitis exfoliative—Doxorubicin—prostate cancer	0.00019	0.00171	CcSEcCtD
Adapalene—Dermatitis bullous—Doxorubicin—prostate cancer	0.000188	0.00169	CcSEcCtD
Adapalene—Pain—Estradiol—prostate cancer	0.000188	0.00169	CcSEcCtD
Adapalene—Face oedema—Epirubicin—prostate cancer	0.000188	0.00168	CcSEcCtD
Adapalene—Convulsion—Etoposide—prostate cancer	0.000181	0.00162	CcSEcCtD
Adapalene—Dry skin—Epirubicin—prostate cancer	0.000178	0.0016	CcSEcCtD
Adapalene—Pain—Mitoxantrone—prostate cancer	0.000175	0.00157	CcSEcCtD
Adapalene—Rash—Goserelin—prostate cancer	0.000175	0.00157	CcSEcCtD
Adapalene—Dermatitis—Goserelin—prostate cancer	0.000175	0.00157	CcSEcCtD
Adapalene—Urticaria—Estradiol—prostate cancer	0.000175	0.00157	CcSEcCtD
Adapalene—Face oedema—Doxorubicin—prostate cancer	0.000174	0.00156	CcSEcCtD
Adapalene—Erythema—Docetaxel—prostate cancer	0.000173	0.00156	CcSEcCtD
Adapalene—Rash—Conjugated Estrogens—prostate cancer	0.000173	0.00155	CcSEcCtD
Adapalene—Dermatitis—Conjugated Estrogens—prostate cancer	0.000173	0.00155	CcSEcCtD
Adapalene—Erythema—Capecitabine—prostate cancer	0.000168	0.00151	CcSEcCtD
Adapalene—Dry skin—Doxorubicin—prostate cancer	0.000165	0.00148	CcSEcCtD
Adapalene—Urticaria—Mitoxantrone—prostate cancer	0.000163	0.00146	CcSEcCtD
Adapalene—Hypersensitivity—Estradiol—prostate cancer	0.000162	0.00145	CcSEcCtD
Adapalene—Pruritus—Estradiol—prostate cancer	0.000155	0.0014	CcSEcCtD
Adapalene—Photosensitivity reaction—Epirubicin—prostate cancer	0.000153	0.00138	CcSEcCtD
Adapalene—Hypersensitivity—Mitoxantrone—prostate cancer	0.000151	0.00135	CcSEcCtD
Adapalene—Convulsion—Docetaxel—prostate cancer	0.00015	0.00135	CcSEcCtD
Adapalene—Erythema—Prednisone—prostate cancer	0.00015	0.00134	CcSEcCtD
Adapalene—Pain—Etoposide—prostate cancer	0.000146	0.00131	CcSEcCtD
Adapalene—Conjunctivitis—Epirubicin—prostate cancer	0.000146	0.00131	CcSEcCtD
Adapalene—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000142	0.00127	CcSEcCtD
Adapalene—Rash—Estradiol—prostate cancer	0.000139	0.00124	CcSEcCtD
Adapalene—Dermatitis—Estradiol—prostate cancer	0.000138	0.00124	CcSEcCtD
Adapalene—Angioedema—Prednisone—prostate cancer	0.000137	0.00123	CcSEcCtD
Adapalene—Urticaria—Etoposide—prostate cancer	0.000135	0.00121	CcSEcCtD
Adapalene—Conjunctivitis—Doxorubicin—prostate cancer	0.000135	0.00121	CcSEcCtD
Adapalene—Hepatitis—Epirubicin—prostate cancer	0.000134	0.00121	CcSEcCtD
Adapalene—Convulsion—Prednisone—prostate cancer	0.00013	0.00116	CcSEcCtD
Adapalene—Rash—Mitoxantrone—prostate cancer	0.000129	0.00116	CcSEcCtD
Adapalene—Dermatitis—Mitoxantrone—prostate cancer	0.000129	0.00116	CcSEcCtD
Adapalene—Hypersensitivity—Etoposide—prostate cancer	0.000125	0.00113	CcSEcCtD
Adapalene—Hepatitis—Doxorubicin—prostate cancer	0.000124	0.00112	CcSEcCtD
Adapalene—Pain—Docetaxel—prostate cancer	0.000121	0.00109	CcSEcCtD
Adapalene—Pruritus—Etoposide—prostate cancer	0.000121	0.00108	CcSEcCtD
Adapalene—Pain—Capecitabine—prostate cancer	0.000117	0.00105	CcSEcCtD
Adapalene—Erythema—Epirubicin—prostate cancer	0.000117	0.00105	CcSEcCtD
Adapalene—Urticaria—Capecitabine—prostate cancer	0.000109	0.000977	CcSEcCtD
Adapalene—Erythema—Doxorubicin—prostate cancer	0.000108	0.000972	CcSEcCtD
Adapalene—Rash—Etoposide—prostate cancer	0.000107	0.000964	CcSEcCtD
Adapalene—Dermatitis—Etoposide—prostate cancer	0.000107	0.000963	CcSEcCtD
Adapalene—Hypersensitivity—Docetaxel—prostate cancer	0.000104	0.000936	CcSEcCtD
Adapalene—Convulsion—Epirubicin—prostate cancer	0.000101	0.00091	CcSEcCtD
Adapalene—Hypersensitivity—Capecitabine—prostate cancer	0.000101	0.000906	CcSEcCtD
Adapalene—Pruritus—Docetaxel—prostate cancer	0.0001	0.000899	CcSEcCtD
Adapalene—Urticaria—Prednisone—prostate cancer	9.7e-05	0.000871	CcSEcCtD
Adapalene—Pruritus—Capecitabine—prostate cancer	9.7e-05	0.00087	CcSEcCtD
Adapalene—Convulsion—Doxorubicin—prostate cancer	9.38e-05	0.000842	CcSEcCtD
Adapalene—Hypersensitivity—Prednisone—prostate cancer	8.99e-05	0.000807	CcSEcCtD
Adapalene—Rash—Docetaxel—prostate cancer	8.92e-05	0.000801	CcSEcCtD
Adapalene—Dermatitis—Docetaxel—prostate cancer	8.92e-05	0.0008	CcSEcCtD
Adapalene—Rash—Capecitabine—prostate cancer	8.64e-05	0.000776	CcSEcCtD
Adapalene—Pruritus—Prednisone—prostate cancer	8.64e-05	0.000775	CcSEcCtD
Adapalene—Dermatitis—Capecitabine—prostate cancer	8.63e-05	0.000775	CcSEcCtD
Adapalene—Pain—Epirubicin—prostate cancer	8.16e-05	0.000733	CcSEcCtD
Adapalene—Rash—Prednisone—prostate cancer	7.7e-05	0.000691	CcSEcCtD
Adapalene—Dermatitis—Prednisone—prostate cancer	7.69e-05	0.00069	CcSEcCtD
Adapalene—Urticaria—Epirubicin—prostate cancer	7.58e-05	0.000681	CcSEcCtD
Adapalene—Pain—Doxorubicin—prostate cancer	7.55e-05	0.000678	CcSEcCtD
Adapalene—Hypersensitivity—Epirubicin—prostate cancer	7.03e-05	0.000631	CcSEcCtD
Adapalene—Urticaria—Doxorubicin—prostate cancer	7.02e-05	0.00063	CcSEcCtD
Adapalene—Pruritus—Epirubicin—prostate cancer	6.75e-05	0.000606	CcSEcCtD
Adapalene—Hypersensitivity—Doxorubicin—prostate cancer	6.51e-05	0.000584	CcSEcCtD
Adapalene—Pruritus—Doxorubicin—prostate cancer	6.25e-05	0.000561	CcSEcCtD
Adapalene—Rash—Epirubicin—prostate cancer	6.02e-05	0.00054	CcSEcCtD
Adapalene—Dermatitis—Epirubicin—prostate cancer	6.01e-05	0.00054	CcSEcCtD
Adapalene—Rash—Doxorubicin—prostate cancer	5.57e-05	0.0005	CcSEcCtD
Adapalene—Dermatitis—Doxorubicin—prostate cancer	5.56e-05	0.0005	CcSEcCtD
Adapalene—RXRG—Gene Expression—NCOA1—prostate cancer	2.38e-05	0.00012	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	2.36e-05	0.000119	CbGpPWpGaD
Adapalene—RARB—Gene Expression—NCOA1—prostate cancer	2.33e-05	0.000118	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—AR—prostate cancer	2.32e-05	0.000117	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	2.32e-05	0.000117	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	2.3e-05	0.000117	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—PRKCQ—prostate cancer	2.3e-05	0.000116	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—NCOA2—prostate cancer	2.3e-05	0.000116	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—AR—prostate cancer	2.28e-05	0.000115	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—NCOA1—prostate cancer	2.28e-05	0.000115	CbGpPWpGaD
Adapalene—RARG—Gene Expression—SIRT1—prostate cancer	2.27e-05	0.000115	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—TGFB1—prostate cancer	2.27e-05	0.000115	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—RXRA—prostate cancer	2.26e-05	0.000115	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—EIF3A—prostate cancer	2.25e-05	0.000114	CbGpPWpGaD
Adapalene—RXRA—Metabolism—TNFRSF21—prostate cancer	2.24e-05	0.000114	CbGpPWpGaD
Adapalene—RARG—Gene Expression—VDR—prostate cancer	2.24e-05	0.000113	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—NCOA1—prostate cancer	2.24e-05	0.000113	CbGpPWpGaD
Adapalene—RARA—Gene Expression—NCOA1—prostate cancer	2.24e-05	0.000113	CbGpPWpGaD
Adapalene—RARB—Gene Expression—AR—prostate cancer	2.24e-05	0.000113	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	2.22e-05	0.000112	CbGpPWpGaD
Adapalene—RARB—Gene Expression—RXRA—prostate cancer	2.22e-05	0.000112	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—SLC5A5—prostate cancer	2.19e-05	0.000111	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—FGF10—prostate cancer	2.19e-05	0.000111	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP7B1—prostate cancer	2.18e-05	0.00011	CbGpPWpGaD
Adapalene—RXRA—Metabolism—MTAP—prostate cancer	2.18e-05	0.00011	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	2.18e-05	0.00011	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—AR—prostate cancer	2.15e-05	0.000109	CbGpPWpGaD
Adapalene—RARA—Gene Expression—AR—prostate cancer	2.15e-05	0.000109	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	2.14e-05	0.000108	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	2.13e-05	0.000108	CbGpPWpGaD
Adapalene—RARA—Gene Expression—RXRA—prostate cancer	2.13e-05	0.000108	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—RXRA—prostate cancer	2.13e-05	0.000108	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SULT1E1—prostate cancer	2.13e-05	0.000108	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SRD5A1—prostate cancer	2.13e-05	0.000108	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—VAV3—prostate cancer	2.11e-05	0.000107	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—VDR—prostate cancer	2.09e-05	0.000106	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	2.08e-05	0.000105	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—SIRT1—prostate cancer	2.08e-05	0.000105	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	2.07e-05	0.000105	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—TGFB1—prostate cancer	2.06e-05	0.000104	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	2.06e-05	0.000104	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—VDR—prostate cancer	2.05e-05	0.000104	CbGpPWpGaD
Adapalene—RARG—Gene Expression—ERCC2—prostate cancer	2.05e-05	0.000104	CbGpPWpGaD
Adapalene—RARB—Gene Expression—SIRT1—prostate cancer	2.04e-05	0.000103	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	2.04e-05	0.000103	CbGpPWpGaD
Adapalene—RXRA—Metabolism—HSD17B3—prostate cancer	2.03e-05	0.000103	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ACSL4—prostate cancer	2.03e-05	0.000103	CbGpPWpGaD
Adapalene—RARG—Gene Expression—NR3C1—prostate cancer	2.02e-05	0.000102	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	2.01e-05	0.000102	CbGpPWpGaD
Adapalene—RARB—Gene Expression—VDR—prostate cancer	2.01e-05	0.000102	CbGpPWpGaD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—prostate cancer	2.01e-05	0.000102	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	2.01e-05	0.000102	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.01e-05	0.000102	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—SIRT1—prostate cancer	1.96e-05	9.9e-05	CbGpPWpGaD
Adapalene—RARA—Gene Expression—SIRT1—prostate cancer	1.96e-05	9.9e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ARG2—prostate cancer	1.95e-05	9.85e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PHGDH—prostate cancer	1.95e-05	9.85e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—UMPS—prostate cancer	1.95e-05	9.85e-05	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.94e-05	9.8e-05	CbGpPWpGaD
Adapalene—RARA—Gene Expression—VDR—prostate cancer	1.93e-05	9.75e-05	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—VDR—prostate cancer	1.93e-05	9.75e-05	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	1.92e-05	9.69e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—LDHB—prostate cancer	1.91e-05	9.66e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—DNMT3B—prostate cancer	1.9e-05	9.6e-05	CbGpPWpGaD
Adapalene—RARG—Gene Expression—PPARA—prostate cancer	1.89e-05	9.57e-05	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—NR3C1—prostate cancer	1.88e-05	9.5e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—LPL—prostate cancer	1.88e-05	9.49e-05	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—ERCC2—prostate cancer	1.87e-05	9.49e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP3A5—prostate cancer	1.87e-05	9.48e-05	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	1.86e-05	9.43e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—RPL10—prostate cancer	1.86e-05	9.41e-05	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—MYC—prostate cancer	1.85e-05	9.36e-05	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—NR3C1—prostate cancer	1.85e-05	9.34e-05	CbGpPWpGaD
Adapalene—RARB—Gene Expression—ERCC2—prostate cancer	1.84e-05	9.3e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—HIST1H2BG—prostate cancer	1.83e-05	9.24e-05	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	1.81e-05	9.18e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—ITGB3—prostate cancer	1.81e-05	9.16e-05	CbGpPWpGaD
Adapalene—RARB—Gene Expression—NR3C1—prostate cancer	1.81e-05	9.16e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PDHA1—prostate cancer	1.81e-05	9.16e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—TCN2—prostate cancer	1.81e-05	9.16e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—UCP3—prostate cancer	1.81e-05	9.16e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTA3—prostate cancer	1.81e-05	9.16e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—NPPA—prostate cancer	1.76e-05	8.92e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—HIST1H4H—prostate cancer	1.76e-05	8.92e-05	CbGpPWpGaD
Adapalene—RARA—Gene Expression—ERCC2—prostate cancer	1.76e-05	8.92e-05	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—ERCC2—prostate cancer	1.76e-05	8.92e-05	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—PPARA—prostate cancer	1.76e-05	8.9e-05	CbGpPWpGaD
Adapalene—RARA—Gene Expression—NR3C1—prostate cancer	1.73e-05	8.78e-05	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—NR3C1—prostate cancer	1.73e-05	8.78e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—MED12—prostate cancer	1.73e-05	8.78e-05	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—PPARA—prostate cancer	1.73e-05	8.75e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—HSD3B1—prostate cancer	1.73e-05	8.73e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SLC22A3—prostate cancer	1.73e-05	8.73e-05	CbGpPWpGaD
Adapalene—RARG—Gene Expression—ESR1—prostate cancer	1.71e-05	8.67e-05	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—IL6—prostate cancer	1.71e-05	8.64e-05	CbGpPWpGaD
Adapalene—RARB—Gene Expression—PPARA—prostate cancer	1.7e-05	8.58e-05	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—MYC—prostate cancer	1.69e-05	8.56e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.67e-05	8.47e-05	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	1.67e-05	8.45e-05	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	1.67e-05	8.43e-05	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—MYC—prostate cancer	1.66e-05	8.4e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—PPARA—prostate cancer	1.66e-05	8.38e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTA4—prostate cancer	1.65e-05	8.37e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—TBXAS1—prostate cancer	1.65e-05	8.37e-05	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	1.63e-05	8.26e-05	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—PPARA—prostate cancer	1.63e-05	8.23e-05	CbGpPWpGaD
Adapalene—RARA—Gene Expression—PPARA—prostate cancer	1.63e-05	8.23e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.62e-05	8.18e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTA2—prostate cancer	1.61e-05	8.16e-05	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—ESR1—prostate cancer	1.59e-05	8.07e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ABCG5—prostate cancer	1.59e-05	8.06e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SULT1A1—prostate cancer	1.59e-05	8.06e-05	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—MYC—prostate cancer	1.59e-05	8.05e-05	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—MYC—prostate cancer	1.59e-05	8.05e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—LEP—prostate cancer	1.57e-05	7.95e-05	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—ESR1—prostate cancer	1.57e-05	7.93e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTA1—prostate cancer	1.56e-05	7.87e-05	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	1.54e-05	7.81e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—KDR—prostate cancer	1.54e-05	7.79e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NAT2—prostate cancer	1.54e-05	7.78e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTO1—prostate cancer	1.54e-05	7.78e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—HSD3B2—prostate cancer	1.54e-05	7.78e-05	CbGpPWpGaD
Adapalene—RARB—Gene Expression—ESR1—prostate cancer	1.54e-05	7.77e-05	CbGpPWpGaD
Adapalene—RARG—Gene Expression—CREBBP—prostate cancer	1.5e-05	7.6e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.48e-05	7.49e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—RPS19—prostate cancer	1.48e-05	7.46e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PLCB2—prostate cancer	1.47e-05	7.46e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP2C18—prostate cancer	1.47e-05	7.46e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—LRP2—prostate cancer	1.47e-05	7.46e-05	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—ESR1—prostate cancer	1.47e-05	7.45e-05	CbGpPWpGaD
Adapalene—RARA—Gene Expression—ESR1—prostate cancer	1.47e-05	7.45e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—P4HB—prostate cancer	1.45e-05	7.32e-05	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	1.42e-05	7.17e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—DNMT1—prostate cancer	1.41e-05	7.13e-05	CbGpPWpGaD
Adapalene—RARG—Gene Expression—SERPINE1—prostate cancer	1.41e-05	7.12e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SLC22A1—prostate cancer	1.41e-05	7.12e-05	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—PPARA—prostate cancer	1.41e-05	7.12e-05	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—CREBBP—prostate cancer	1.4e-05	7.07e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.39e-05	7.04e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—NCOA2—prostate cancer	1.38e-05	7e-05	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—CREBBP—prostate cancer	1.37e-05	6.95e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SULT2A1—prostate cancer	1.37e-05	6.94e-05	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.37e-05	6.94e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—EZH2—prostate cancer	1.37e-05	6.91e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—GSK3B—prostate cancer	1.36e-05	6.89e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—MED12—prostate cancer	1.35e-05	6.83e-05	CbGpPWpGaD
Adapalene—RARB—Gene Expression—CREBBP—prostate cancer	1.35e-05	6.81e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—INS—prostate cancer	1.34e-05	6.79e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GNG5—prostate cancer	1.34e-05	6.77e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—PARP1—prostate cancer	1.34e-05	6.76e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—CREBBP—prostate cancer	1.32e-05	6.66e-05	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—SERPINE1—prostate cancer	1.31e-05	6.63e-05	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—CREBBP—prostate cancer	1.29e-05	6.53e-05	CbGpPWpGaD
Adapalene—RARA—Gene Expression—CREBBP—prostate cancer	1.29e-05	6.53e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NCOA3—prostate cancer	1.29e-05	6.52e-05	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—SERPINE1—prostate cancer	1.29e-05	6.52e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.27e-05	6.41e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—HSPA1A—prostate cancer	1.27e-05	6.4e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—ESR2—prostate cancer	1.27e-05	6.4e-05	CbGpPWpGaD
Adapalene—RARB—Gene Expression—SERPINE1—prostate cancer	1.26e-05	6.39e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MMP2—prostate cancer	1.26e-05	6.36e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MAP2K1—prostate cancer	1.26e-05	6.35e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—HPGDS—prostate cancer	1.23e-05	6.22e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP2C19—prostate cancer	1.22e-05	6.18e-05	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—SERPINE1—prostate cancer	1.21e-05	6.13e-05	CbGpPWpGaD
Adapalene—RARA—Gene Expression—SERPINE1—prostate cancer	1.21e-05	6.13e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—FGF2—prostate cancer	1.19e-05	6.04e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTT1—prostate cancer	1.19e-05	6.04e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ACHE—prostate cancer	1.19e-05	6.04e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP2A6—prostate cancer	1.18e-05	5.97e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.17e-05	5.94e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—NCOA1—prostate cancer	1.17e-05	5.9e-05	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.16e-05	5.86e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—AKR1C3—prostate cancer	1.15e-05	5.8e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—JAK2—prostate cancer	1.14e-05	5.79e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PRKACB—prostate cancer	1.14e-05	5.77e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP17A1—prostate cancer	1.13e-05	5.71e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—AR—prostate cancer	1.12e-05	5.66e-05	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.12e-05	5.65e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.11e-05	5.64e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—ERBB2—prostate cancer	1.1e-05	5.57e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NCOA2—prostate cancer	1.08e-05	5.44e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SLC5A5—prostate cancer	1.03e-05	5.19e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—SIRT1—prostate cancer	1.02e-05	5.16e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—VDR—prostate cancer	1e-05	5.08e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP2E1—prostate cancer	1e-05	5.07e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NQO1—prostate cancer	9.91e-06	5.02e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—TH—prostate cancer	9.77e-06	4.94e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	9.71e-06	4.91e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP3A4—prostate cancer	9.67e-06	4.89e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—CTNNB1—prostate cancer	9.64e-06	4.88e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	9.62e-06	4.87e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP1B1—prostate cancer	9.5e-06	4.81e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MMP9—prostate cancer	9.45e-06	4.78e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GGT1—prostate cancer	9.2e-06	4.66e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—ERCC2—prostate cancer	9.19e-06	4.65e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NCOA1—prostate cancer	9.07e-06	4.59e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—NR3C1—prostate cancer	9.04e-06	4.58e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—EP300—prostate cancer	8.96e-06	4.53e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP19A1—prostate cancer	8.94e-06	4.52e-05	CbGpPWpGaD
Adapalene—RARG—Gene Expression—MYC—prostate cancer	8.91e-06	4.51e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—SRC—prostate cancer	8.71e-06	4.41e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—VEGFA—prostate cancer	8.48e-06	4.29e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—PPARA—prostate cancer	8.47e-06	4.29e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—STAT3—prostate cancer	8.4e-06	4.25e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	8.39e-06	4.24e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—COMT—prostate cancer	8.31e-06	4.2e-05	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—MYC—prostate cancer	8.29e-06	4.2e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTP1—prostate cancer	8.27e-06	4.18e-05	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—MYC—prostate cancer	8.15e-06	4.12e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ITPR1—prostate cancer	8.14e-06	4.12e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—EP300—prostate cancer	8e-06	4.05e-05	CbGpPWpGaD
Adapalene—RARB—Gene Expression—MYC—prostate cancer	7.99e-06	4.04e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TGFB1—prostate cancer	7.79e-06	3.94e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—TYMS—prostate cancer	7.69e-06	3.89e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—ESR1—prostate cancer	7.68e-06	3.88e-05	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—MYC—prostate cancer	7.66e-06	3.88e-05	CbGpPWpGaD
Adapalene—RARA—Gene Expression—MYC—prostate cancer	7.66e-06	3.88e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—EGFR—prostate cancer	7.63e-06	3.86e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTM1—prostate cancer	7.6e-06	3.84e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—LPL—prostate cancer	7.46e-06	3.77e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—KRAS—prostate cancer	7.21e-06	3.65e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP1A1—prostate cancer	7.2e-06	3.64e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ERCC2—prostate cancer	7.14e-06	3.61e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—CREBBP—prostate cancer	6.73e-06	3.4e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—MTHFR—prostate cancer	6.72e-06	3.4e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PPARA—prostate cancer	6.59e-06	3.33e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—SERPINE1—prostate cancer	6.31e-06	3.19e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CAV1—prostate cancer	6.19e-06	3.13e-05	CbGpPWpGaD
Adapalene—RARG—Gene Expression—AKT1—prostate cancer	6.18e-06	3.13e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.92e-06	2.99e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—IL6—prostate cancer	5.87e-06	2.97e-05	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—AKT1—prostate cancer	5.65e-06	2.86e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PIK3CG—prostate cancer	5.64e-06	2.85e-05	CbGpPWpGaD
Adapalene—RARB—Gene Expression—AKT1—prostate cancer	5.54e-06	2.8e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—AKT1—prostate cancer	5.41e-06	2.74e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—INS—prostate cancer	5.34e-06	2.7e-05	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—AKT1—prostate cancer	5.31e-06	2.69e-05	CbGpPWpGaD
Adapalene—RARA—Gene Expression—AKT1—prostate cancer	5.31e-06	2.69e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CREBBP—prostate cancer	5.23e-06	2.65e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PIK3CD—prostate cancer	4.96e-06	2.51e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NOS3—prostate cancer	4.68e-06	2.37e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PIK3CB—prostate cancer	4.32e-06	2.19e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PTGS2—prostate cancer	4.28e-06	2.17e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—MYC—prostate cancer	3.99e-06	2.02e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PTEN—prostate cancer	3.74e-06	1.89e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—EP300—prostate cancer	3.56e-06	1.8e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—AKT1—prostate cancer	2.77e-06	1.4e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PIK3CA—prostate cancer	2.64e-06	1.33e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—AKT1—prostate cancer	2.15e-06	1.09e-05	CbGpPWpGaD
